Ergotamine in the acute treatment of migraine: a review and European consensus
about
Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriersThe Migraine-Stroke ConnectionPolypharmacy in Older Adults With Hypertension: A Comprehensive ReviewOptimal management of severe nausea and vomiting in migraine: improving patient outcomesStructural insights into ligand recognition and selectivity for classes A, B, and C GPCRsMigraine: diagnosis and managementThe impact of different antimigraine compounds on platelet and erythrocyte aggregationEFNS guideline on the drug treatment of migraine - report of an EFNS task forceItalian guidelines for primary headaches: 2012 revised versionErgot and triptan overuse in Austria--an evaluation of clinical data and cost.Migraine pathogenesis and state of pharmacological treatment optionsErgotism with ischemia in all four extremities: a case reportTriptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.Treatment of status migrainosus.Human and cattle ergotism since 1900: symptoms, outbreaks, and regulations.Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.Acute Migraine Treatment in Adults.Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.Indolealkylamines: biotransformations and potential drug-drug interactionsErgotism in Norway. Part 1: The symptoms and their interpretation from the late Iron Age to the seventeenth century.Rhodococcus erythropolis MTHt3 biotransforms ergopeptines to lysergic acidDopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.Ischemic colitis secondary to ergotamine use: a case studySumatriptan: a decade of use and experience in the treatment of migraine.The acute and preventative treatment of episodic migraine.Can we develop neurally acting drugs for the treatment of migraine?The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.A review of evidence-based medicine and meta-analytic reviews in migraine.Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.Migraine in the elderly: a review.Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.Current migraine management - patient acceptability and future approaches.Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment.History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.Migraine and ischemic stroke: a debated question.The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.Almotriptan for the treatment of acute migraine: a review of early intervention trials.
P2860
Q24676273-53659E03-88F1-4939-A92A-23265BF7CB25Q26747260-B7A85B64-6DF4-4317-AC31-E92D4A30965EQ26799236-A41BA73A-D108-4C0C-A513-4663A8FFA4D1Q26830422-2DE662A8-6D9B-4BD0-92FF-8C54EEE6FA37Q28088311-6EF19497-B802-4291-A8DF-C6B70F022637Q28165454-3759ACC6-97A7-453C-A26F-FD5C7C0A1432Q28199978-A0299818-F5D2-4170-84C6-9FF1D5D4101DQ28219436-EB1A8A07-0C4D-4CAB-AD6A-93BDED645718Q30466790-E29BD691-16EC-4870-BA57-118F321068DAQ30755711-485248EB-228E-4C02-9BB2-E85241CCB0BAQ30886663-DBFC4487-7D1C-4C06-BCAC-665291038BE4Q33790861-58E1A213-D3F9-43A9-BBEC-B77CCA012456Q34154647-9D3A5C10-27DB-408C-81B2-4C191034B8B5Q34180539-E15F2C6F-52B3-4CFA-B64F-0904109B858CQ34240939-071F985D-F46F-498D-B4C9-9EE4BE936A3BQ34294759-D4754B98-B1BC-44C5-928C-F03B9DBE9667Q34396223-FD6A3828-7BAE-49CF-9808-12AEBD5E0B87Q34471863-5D9977B2-DE76-4614-AFC6-5EDCAA088DC4Q34691359-9594A462-EF88-4C94-A6AA-F4832DF1D374Q34775667-F76D9D48-DDF1-4E07-A407-38EA35CDE041Q35103476-3574A2F7-3ACE-42E1-91A6-F29EA5F88096Q35544634-7FA839EB-00FF-4A11-A59C-B3DB5AF14F22Q35644029-E774EFE9-72D7-47F2-B780-9C75E69D3A6FQ35688196-6F9C2EB9-35CC-4B4B-92FB-27BE780AC80CQ35759798-9AA28930-9611-41CA-9629-FFF778DFD52DQ36107080-250C598B-DC29-4FF7-A1BE-FB687643A663Q36239483-A00B315C-80F4-4588-9208-092ABF8F55A4Q36240187-B05294F8-05C0-4285-AE15-57668AC1FE02Q36340711-1EDC1B4B-379B-4AF9-B57F-26293962C597Q36632277-3AE4F3E9-0B08-419F-A859-79508388E4CFQ36662888-62B7AE8F-0A84-4F46-9E6B-2FA49E5037C2Q36719748-8A328B4A-9EAA-43B2-A59A-FC7D9F88D38EQ37030669-EBF65C13-BD95-4B9E-AAF4-952C36395D7AQ37081979-10E81F7C-E5A1-4C39-B1A8-893A5EBAB003Q37106936-0C244B14-63D6-4A16-A0C5-8E2B10C3BFAFQ37123478-5AE54A41-B568-41D5-8A66-D2D1BA3556B9Q37155841-C6CDE228-C32E-437F-B103-C653747C26F8Q37156443-A6CDBF5C-DF0B-45D4-AF8D-83F2AE206A86Q37247876-D85383A1-47C0-4EFD-836E-B35482BE78CBQ37699415-C748C41E-4937-4EBA-A3D3-F59848E35F47
P2860
Ergotamine in the acute treatment of migraine: a review and European consensus
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Ergotamine in the acute treatment of migraine: a review and European consensus
@ast
Ergotamine in the acute treatment of migraine: a review and European consensus
@en
Ergotamine in the acute treatment of migraine: a review and European consensus
@nl
type
label
Ergotamine in the acute treatment of migraine: a review and European consensus
@ast
Ergotamine in the acute treatment of migraine: a review and European consensus
@en
Ergotamine in the acute treatment of migraine: a review and European consensus
@nl
prefLabel
Ergotamine in the acute treatment of migraine: a review and European consensus
@ast
Ergotamine in the acute treatment of migraine: a review and European consensus
@en
Ergotamine in the acute treatment of migraine: a review and European consensus
@nl
P2093
P50
P3181
P356
P1433
P1476
Ergotamine in the acute treatment of migraine: a review and European consensus
@en
P2093
P3181
P356
10.1093/BRAIN/123.1.9
P407
P478
123 ( Pt 1)
P577
2000-01-01T00:00:00Z